Kristy Parker
Psychiatric/Mental Health · Shreveport, LANPI 1134894173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 28.5% of the total. Reporting peaked in 2023 at $1,190 and has fallen 56.8% since, to $514 in 2025.
Across 185 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$411
- Lundbeck LLC$404
- Alkermes, Inc.$324
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$304
- Neurocrine Biosciences, Inc.$294
- plus $948 from 12 others
What the payments were for
- Food & beverage$3,66297%
- Education$973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 39 | $1,073 |
| Otsuka America Pharmaceutical, Inc. | 25 | $411 |
| Lundbeck LLC | 18 | $404 |
| Alkermes, Inc. | 18 | $324 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $304 |
| Neurocrine Biosciences, Inc. | 25 | $294 |
| Johnson & Johnson | 12 | $264 |
| Corium, LLC | 2 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $138 |
| Sunovion Pharmaceuticals Inc. | 7 | $94 |
| Ironshore Pharmaceuticals Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| Bioxcel Therapeutics, Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| AbbVie | 1 | $25 |
| Indivior Inc. | 1 | $17 |
| Braeburn Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$250
- Azstarys$125
- UZEDY$125
How this compares
$3,758 in reported general payments places this provider in the 75th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Shreveport
- Kimberly ForcinelShreveport$92K
- Zachary FussellShreveport$9K
- Lisa BakerShreveport$9K
- Jaschandria BellShreveport$8K
- Shannon JacksonShreveport$8K
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.